Julie Ann Luk
About Julie Ann Luk
Julie Ann Luk is the Director of Clinical Operations and Early Portfolio Management at AlloVir, where she oversees clinical drug development programs. With extensive experience in clinical trials and a strong educational background, she has held significant roles at SST Corporation, Merck, and Schering-Plough Research Institute.
Current Role at AlloVir
Julie Ann Luk serves as the Director of Clinical Operations and Early Portfolio Management at AlloVir since 2021. In this role, she oversees clinical drug development programs, ensuring that projects progress efficiently through various stages of development. Her responsibilities include managing clinical trials and developing strategies to enhance operational processes within the clinical trial framework.
Previous Experience at Merck
Before joining AlloVir, Julie Ann Luk worked at Merck for 16 years as an Associate Principal Scientist in Early Stage Development Operations. During her tenure from 2005 to 2021 in Rahway, NJ, she contributed to the management of clinical trials and played a significant role in early-stage drug development initiatives.
Experience at SST Corporation
Julie Ann Luk began her career as a Regulatory Affairs Specialist at SST Corporation in Clifton, NJ, where she worked for one year from 2004 to 2005. This position provided her with foundational experience in regulatory processes within the pharmaceutical industry.
Education and Expertise
Julie Ann Luk holds a Bachelor's Degree in Biology from Rutgers, The State University of New Jersey-Newark. She also earned a Graduate Certificate in Clinical Research Administration from The George Washington University School of Medicine and Health Sciences. Her educational background supports her expertise in managing clinical trials across all phases, from Phase 1 to Phase 4, and leading clinical operations effectively.
Role at Schering-Plough Research Institute
Prior to her time at Merck, Julie Ann Luk worked as a Clinical Information Specialist at Schering-Plough Research Institute for seven months in 2003 to 2004 in Springfield, NJ. This role contributed to her knowledge and skills in clinical research and information management within the pharmaceutical sector.